The WID-BC-index identifies women with primary poor prognostic

The WID-BC-index identifies women with primary poor prognostic

4.7
(454)
Write Review
More
$ 20.99
Add to Cart
In stock
Description

Brain metastasis-associated fibroblasts secrete fucosylated PVR/CD155 that induces breast cancer invasion - ScienceDirect

Primary and secondary tumors of the peritoneum: key imaging features and differential diagnosis with surgical and pathological correlation, Insights into Imaging

Assessing the risk of cervical neoplasia in the post‐HPV vaccination era - Lehtinen - 2023 - International Journal of Cancer - Wiley Online Library

Daily progesterone concentrations throughout the estrous cycle.

Distinct shared and compartment-enriched oncogenic networks drive primary versus metastatic breast cancer

The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples

GitHub - chiaraherzog/WID-BC-source-data: Source data for the WID-BC-index manuscript, The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples by James E. Barrett, Chiara Herzog

Polycystic Ovary Syndrome Risk Factors among Women in Baghdad: A Case-Control study - Tarbiat Modares University Journals System - Health Education and Health Promotion

Frontiers Integrated transcriptome and network analysis identifies EZH2/CCNB1/PPARG as prognostic factors in breast cancer

Evaluation of circulating plasma proteins in breast cancer using Mendelian randomisation

Primary and secondary tumors of the peritoneum: key imaging features and differential diagnosis with surgical and pathological correlation, Insights into Imaging

ETS-1-activated LINC01016 over-expression promotes tumor progression via suppression of RFFL-mediated DHX9 ubiquitination degradation in breast cancers

PDF) The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples

DNA methylation at quantitative trait loci (mQTLs) varies with cell type and nonheritable factors and may improve breast cancer risk assessment